Faculty Publications

Phase II study of Bevacizumab and Erlotinib in treatment-naive elderly patients (> 70 years of age) with advanced Non-Small Cell Lung Cancer (NSCLC)

Borghaei H, Mehra R, Millenson M, Tuttle H, Ruth KJ, Magdelinski A, Mintzer D, Simon G, Langer C

Phase II study of Bevacizumab and Erlotinib in treatment-naive elderly patients (> 70 years of age) with advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology. 2009 Sep;4(9):S667-S668.

Abstract

Last updated on Saturday, November 21, 2009